| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
(Received for publication, April 3, 1996, and in revised form, July 24, 1996)
From the Institute on Aging, Department of Medicine, University of
Wisconsin, Madison, Wisconsin 53706 and the Madison Veterans
Administration GRECC, Madison, Wisconsin 53705
Androgens repress expression of many genes, yet
the mechanism of this activity has remained elusive. The cytokine,
interleukin-6, is active in a variety of biological systems, and its
expression is repressed by androgens. Accordingly we dissected the
mechanism of androgen's ability to inhibit interleukin-6 expression at
the molecular level. In a series of co-transfection assays, we found
that 5
Volume 271, Number 42,
Issue of October 18, 1996
pp. 26267-26275
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
B Activity through Maintenance of IB
Levels Contributes to Dihydrotestosterone-mediated Repression of the
Interleukin-6 Promoter
-dihydrotestosterone, through the androgen receptor, repressed
activation of the interleukin-6 promoter, in part, by inhibiting NF
B
activity. It did not appear that 5-dihydrotestosterone inhibited
NFB by activating the androgen receptor to compete for the NFB
response element as we could not detect androgen receptor binding to
the IL-6 promoter by DNase I footprinting assay. However, by
electrophoretic mobility shift assay we found that
5-dihydrotestosterone repressed formation of NFB·NFB
response element complex formation. In LNCaP prostate carcinoma
cells, 5-dihydrotestosterone achieved this effect through
maintenance of IB protein levels in the face of phorbol ester, a
stimulus that results in IB degradation. Finally, we confirmed
that IB inhibits NFB-mediated activation of the interleukin-6
promoter. These data suggest that maintenance of IB levels may
represent the first identified mechanism for androgen-mediated
repression of a natural androgen-regulated gene.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  M. H. Hong, H. Sun, C. H. Jin, M. Chapman, J. Hu, W. Chang, K. Burnett, J. Rosen, A. Negro-Vilar, and J. N. Miner Cell-Specific Activation of the Human Skeletal {alpha}-Actin by Androgens Endocrinology, March 1, 2008; 149(3): 1103 - 1112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. B. Ershler A gripping reality: oxidative stress, inflammation, and the pathway to frailty J Appl Physiol, July 1, 2007; 103(1): 3 - 5. [Full Text] [PDF]
|
|
|
|
 |
|
 N. GALINDO-SEVILLA, N. SOTO, J. MANCILLA, A. CERBULO, E. ZAMBRANO, R. CHAVIRA, and J. HUERTO LOW SERUM LEVELS OF DEHYDROEPIANDROSTERONE AND CORTISOL IN HUMAN DIFFUSE CUTANEOUS LEISHMANIASIS BY LEISHMANIA MEXICANA Am J Trop Med Hyg, March 1, 2007; 76(3): 566 - 572. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Peant, J.-S. Diallo, L. Lessard, N. Delvoye, C. Le Page, F. Saad, and A.-M. Mes-Masson Regulation of I{kappa}B Kinase {varepsilon} Expression by the Androgen Receptor and the Nuclear Factor-{kappa}B Transcription Factor in Prostate Cancer Mol. Cancer Res., January 1, 2007; 5(1): 87 - 94. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Maggio, J. M. Guralnik, D. L. Longo, and L. Ferrucci Interleukin-6 in aging and chronic disease: a magnificent pathway. J. Gerontol. A Biol. Sci. Med. Sci., June 1, 2006; 61(6): 575 - 584. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Wallner, J. Dai, J. Escara-Wilke, J. Zhang, Z. Yao, Y. Lu, M. Trikha, J. A. Nemeth, M. H. Zaki, and E. T. Keller Inhibition of Interleukin-6 with CNTO328, an Anti-Interleukin-6 Monoclonal Antibody, Inhibits Conversion of Androgen-Dependent Prostate Cancer to an Androgen-Independent Phenotype in Orchiectomized Mice. Cancer Res., March 15, 2006; 66(6): 3087 - 3095. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z.-M. Huang, T. Tan, H. Yoshida, K. Mori, Y. Ma, and T. S. B. Yen Activation of Hepatitis B Virus S Promoter by a Cell Type-Restricted IRE1-Dependent Pathway Induced by Endoplasmic Reticulum Stress Mol. Cell. Biol., September 1, 2005; 25(17): 7522 - 7533. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Roden, M. T. Moser, S. D. Tri, M. Mercader, S. M. Kuntz, H. Dong, A. A. Hurwitz, D. J. McKean, E. Celis, B. C. Leibovich, et al. Augmentation of T Cell Levels and Responses Induced by Androgen Deprivation J. Immunol., November 15, 2004; 173(10): 6098 - 6108. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. N. Papandreou and C. J. Logothetis Bortezomib as a Potential Treatment for Prostate Cancer Cancer Res., August 1, 2004; 64(15): 5036 - 5043. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Chen, A. J. Koh, N. S. Datta, J. Zhang, E. T. Keller, G. Xiao, R. T. Franceschi, N. J. D'Silva, and L. K. McCauley Impact of the Mitogen-activated Protein Kinase Pathway on Parathyroid Hormone-related Protein Actions in Osteoblasts J. Biol. Chem., July 9, 2004; 279(28): 29121 - 29129. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. N. Papandreou, D. D. Daliani, D. Nix, H. Yang, T. Madden, X. Wang, C. S. Pien, R. E. Millikan, S.-M. Tu, L. Pagliaro, et al. Phase I Trial of the Proteasome Inhibitor Bortezomib in Patients With Advanced Solid Tumors With Observations in Androgen-Independent Prostate Cancer J. Clin. Oncol., June 1, 2004; 22(11): 2108 - 2121. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Altuwaijri, H.-K. Lin, K.-H. Chuang, W.-J. Lin, S. Yeh, L. A. Hanchett, M. M. Rahman, H.-Y. Kang, M.-Y. Tsai, Y. Zhang, et al. Interruption of Nuclear Factor {kappa}B Signaling by the Androgen Receptor Facilitates 12-O-Tetradecanoylphorbolacetate-Induced Apoptosis in Androgen-sensitive Prostate Cancer LNCaP Cells Cancer Res., November 1, 2003; 63(21): 7106 - 7112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. De Bosscher, W. Vanden Berghe, and G. Haegeman The Interplay between the Glucocorticoid Receptor and Nuclear Factor-{kappa}B or Activator Protein-1: Molecular Mechanisms for Gene Repression Endocr. Rev., August 1, 2003; 24(4): 488 - 522. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Lukas-Croisier, C. Lasala, J. Nicaud, P. Bedecarras, T. R. Kumar, M. Dutertre, M. M. Matzuk, J.-Y. Picard, N. Josso, and R. Rey Follicle-Stimulating Hormone Increases Testicular Anti-Mullerian Hormone (AMH) Production through Sertoli Cell Proliferation and a Nonclassical Cyclic Adenosine 5'-Monophosphate-Mediated Activation of the AMH Gene Mol. Endocrinol., April 1, 2003; 17(4): 550 - 561. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. D. Chen and C. L. Sawyers NF-{kappa}B Activates Prostate-Specific Antigen Expression and Is Upregulated in Androgen-Independent Prostate Cancer Mol. Cell. Biol., April 15, 2002; 22(8): 2862 - 2870. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Pfeilschifter, R. Koditz, M. Pfohl, and H. Schatz Changes in Proinflammatory Cytokine Activity after Menopause Endocr. Rev., February 1, 2002; 23(1): 90 - 119. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Hobisch, R. Ramoner, D. Fuchs, S. Godoy-Tundidor, G. Bartsch, H. Klocker, and Z. Culig Prostate Cancer Cells (LNCaP) Generated after Long-Term Interleukin 6 (IL-6) Treatment Express IL-6 and Acquire an IL-6 Partially Resistant Phenotype Clin. Cancer Res., September 1, 2001; 7(9): 2941 - 2948. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. S. A. Samy, M. W. Knoferl, R. Zheng, M. G. Schwacha, K. I. Bland, and I. H. Chaudry Divergent Immune Responses in Male and Female Mice after Trauma-Hemorrhage: Dimorphic Alterations in T Lymphocyte Steroidogenic Enzyme Activities Endocrinology, August 1, 2001; 142(8): 3519 - 3529. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.-L. Lin, M. C. Whitney, Z. Yao, and E. T. Keller Interleukin-6 Induces Androgen Responsiveness in Prostate Cancer Cells through Up-Regulation of Androgen Receptor Expression Clin. Cancer Res., June 1, 2001; 7(6): 1773 - 1781. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. K. Mccauley, A. J. Koh-Paige, H. Chen, C. Chen, C. Ontiveros, R. Irwin, and L. R. Mccabe Parathyroid Hormone Stimulates fra-2 Expression in Osteoblastic Cells in Vitro and in Vivo Endocrinology, May 1, 2001; 142(5): 1975 - 1981. [Abstract] [Full Text]
|
|
|
|
 |
|
 K. S. Kanik, G. P. Chrousos, H. R. Schumacher, M. L. Crane, C. H. Yarboro, and R. L. Wilder Adrenocorticotropin, Glucocorticoid, and Androgen Secretion in Patients with New Onset Synovitis/Rheumatoid Arthritis: Relations with Indices of Inflammation J. Clin. Endocrinol. Metab., April 1, 2000; 85(4): 1461 - 1466. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. CUTOLO, A. SULLI, B. VILLAGGIO, B. SERIOLO, and S. ACCARDO Relations between steroid hormones and cytokines in rheumatoid arthritis and systemic lupus erythematosus Ann Rheum Dis, October 1, 1998; 57(10): 573 - 577. [Full Text]
|
|
|
|
 |
|
 D. A. Sukovich, K. Kauser, F. D. Shirley, V. DelVecchio, M. Halks-Miller, and G. M. Rubanyi Expression of Interleukin-6 in Atherosclerotic Lesions of Male ApoE-Knockout Mice : Inhibition by 17ß-Estradiol Arterioscler. Thromb. Vasc. Biol., September 1, 1998; 18(9): 1498 - 1505. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Lansink, P. Koolwijk, V. van Hinsbergh, and T. Kooistra Effect of Steroid Hormones and Retinoids on the Formation of Capillary-Like Tubular Structures of Human Microvascular Endothelial Cells in Fibrin Matrices Is Related to Urokinase Expression Blood, August 1, 1998; 92(3): 927 - 938. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Levesque, M. Beaulieu, C. Guillemette, D. W. Hum, and A. Belanger Effect of Interleukins on UGT2B15 and UGT2B17 Steroid Uridine Diphosphate-Glucuronosyltransferase Expression and Activity in the LNCaP Cell Line Endocrinology, May 1, 1998; 139(5): 2375 - 2381. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Song, H. Ugai, K. Ogawa, Y. Wang, A. Sarai, Y. Obata, I. Kanazawa, K. Sun, K. Itakura, and K. K. Yokoyama Two Consecutive Zinc Fingers in Sp1 and in MAZ Are Essential for Interactions with cis-Elements J. Biol. Chem., August 3, 2001; 276(32): 30429 - 30434. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Zheng, T. S. A. Samy, C. P. Schneider, L. W. Rue III, K. I. Bland, and I. H. Chaudry Decreased 5alpha -dihydrotestosterone catabolism suppresses T lymphocyte functions in males after trauma-hemorrhage Am J Physiol Cell Physiol, June 1, 2002; 282(6): C1332 - C1338. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |
